Respiratory
NHS prescribing intelligence on inhalers, spacers, drugs and other devices used in asthma and COPD
The management of respiratory conditions represents a significant percentage of UK community prescribing.With increased NHS focus on the safe and appropriate prescribing of inhaled medicines, GPrX includes a specific respiratory dashboard benchmarking SABA rates at practice level against local and national comparators.
Select from our RxIndexes to see the top-line brand market share movement of some of the most commonly-prescribed inhalers. Full breakdown and trends are available with a GPrX login.
![RxIndex](/images/brand/rxindex-logo.png)
![GPrX Data Ltd](/images/brand/gprx-logo.png)
Ready to start the conversation?
Our friendly team loves talking data. Schedule a chat or an online demo now!